PORCN moonlights in a wnt-independent pathway that regulates cancer cell proliferation

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Covey, Tracy M ^a   Kaur, Simran ^a   Ong, Tina ^a   Proffitt, Kyle D ^a   Wu, Yonghui ^a   Tan, Patrick ^a   Virshup, David M ^a,b,c  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PORCN PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WNT PROTEIN; PORCN PROTEIN, HUMAN; SIGNAL PEPTIDE; WLS PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PALMITOYLATION; RNA INTERFERENCE; WNT SIGNALING PATHWAY; XENOGRAFT; ANIMAL; BREAST TUMOR; FEMALE; GENE SILENCING; GENETICS; HUMAN; METABOLISM; MUTATION; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

MUS;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MUTATION; NEOPLASMS, GLANDULAR AND EPITHELIAL; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84859563501     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034532     Document Type: Article

References (38)

1. Coombs GS, Covey TM, Virshup DM, (2008) Wnt signaling in development, disease and translational medicine. Curr Drug Targets 9: 513-531.
2. Polakis P, (2007) The many ways of Wnt in cancer. Curr Opin Genet Dev 17: 45-51.
3. Kadowaki T, Wilder E, Klingensmith J, Zachary K, Perrimon N, (1996) The segment polarity gene porcupine encodes a putative multitransmembrane protein involved in Wingless processing. Genes Dev 10: 3116-3128.
4. Tanaka K, Okabayashi K, Asashima M, Perrimon N, Kadowaki T, (2000) The evolutionarily conserved porcupine gene family is involved in the processing of the Wnt family. Eur J Biochem 267: 4300-4311.
5. Caricasole A, Ferraro T, Rimland JM, Terstappen GC, (2002) Molecular cloning and initial characterization of the MG61/PORC gene, the human homologue of the Drosophila segment polarity gene Porcupine. Gene 288: 147-157.
6. Galli LM, Burrus LW, (2011) Differential palmit(e)oylation of Wnt1 on C93 and S224 residues has overlapping and distinct consequences. PLoS One 6: e26636.
7. Zhai L, Chaturvedi D, Cumberledge S, (2004) Drosophila wnt-1 undergoes a hydrophobic modification and is targeted to lipid rafts, a process that requires porcupine. J Biol Chem 279: 33220-33227.
8. Komekado H, Yamamoto H, Chiba T, Kikuchi A, (2007) Glycosylation and palmitoylation of Wnt-3a are coupled to produce an active form of Wnt-3a. Genes Cells 12: 521-534.
9. Galli LM, Barnes TL, Secrest SS, Kadowaki T, Burrus LW, (2007) Porcupine-mediated lipid-modification regulates the activity and distribution of Wnt proteins in the chick neural tube. Development 134: 3339-3348.
10. Herr P, Basler K, (2011) Porcupine-mediated lipidation is required for Wnt recognition by Wls. Dev Biol.
11. Takada R, Satomi Y, Kurata T, Ueno N, Norioka S, et al. (2006) Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. Dev Cell 11: 791-801.
12. Biechele S, Cox BJ, Rossant J, (2011) Porcupine homolog is required for canonical Wnt signaling and gastrulation in mouse embryos. Dev Biol 355: 275-285.
13. Barrott JJ, Cash GM, Smith AP, Barrow JR, Murtaugh LC, (2011) Deletion of mouse Porcn blocks Wnt ligand secretion and reveals an ectodermal etiology of human focal dermal hypoplasia/Goltz syndrome. Proc Natl Acad Sci U S A 108: 12752-12757.
14. Chen B, Dodge ME, Tang W, Lu J, Ma Z, et al. (2009) Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5: 100-107.
15. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, et al. (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448-452.
16. Coombs GS, Yu J, Canning CA, Veltri CA, Covey TM, et al. (2010) WLS-dependent secretion of WNT3A requires Ser209 acylation and vacuolar acidification. J Cell Sci 123: 3357-3367.
17. Banziger C, Soldini D, Schutt C, Zipperlen P, Hausmann G, et al. (2006) Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell 125: 509-522.
18. Bartscherer K, Pelte N, Ingelfinger D, Boutros M, (2006) Secretion of Wnt ligands requires Evi, a conserved transmembrane protein. Cell 125: 523-533.
19. Ching W, Nusse R, (2006) A dedicated Wnt secretion factor. Cell 125: 432-433.
20. Fu J, Ivy Yu HM, Maruyama T, Mirando AJ, Hsu W, (2011) Gpr177/mouse Wntless is essential for Wnt-mediated craniofacial and brain development. Dev Dyn 240: 365-371.
21. Doubravska L, Krausova M, Gradl D, Vojtechova M, Tumova L, et al. (2011) Fatty acid modification of Wnt1 and Wnt3a at serine is prerequisite for lipidation at cysteine and is essential for Wnt signalling. Cell Signal 23: 837-848.
22. Srivastava M, Begovic E, Chapman J, Putnam NH, Hellsten U, et al. (2008) The Trichoplax genome and the nature of placozoans. Nature 454: 955-960.
23. McCulloch MW, Coombs GS, Banerjee N, Bugni TS, Cannon KM, et al. (2009) Psammaplin A as a general activator of cell-based signaling assays via HDAC inhibition and studies on some bromotyrosine derivatives. Bioorg Med Chem 17: 2189-2198.
24. Bafico A, Liu G, Goldin L, Harris V, Aaronson SA, (2004) An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 6: 497-506.
25. Benhaj K, Akcali KC, Ozturk M, (2006) Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 15: 701-707.
26. He B, You L, Uematsu K, Xu Z, Lee AY, et al. (2004) A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 6: 7-14.
27. Chen Z, Li J, Li QS, Fan JQ, Dong XM, et al. (2008) Suppression of PPN/MG61 attenuates Wnt/beta-catenin signaling pathway and induces apoptosis in human lung cancer. Oncogene 27: 3483-3488.
28. Bartling B, Rehbein G, Simm A, Silber RE, Hofmann HS, (2010) Porcupine expression is associated with the expression of S100P and other cancer-related molecules in non-small cell lung carcinoma. Int J Oncol 36: 1015-1021.
29. Matsuda Y, Schlange T, Oakeley EJ, Boulay A, Hynes NE, (2009) WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res 11: R32.
30. Rajagopalan S, Xu Y, Brenner MB, (1994) Retention of unassembled components of integral membrane proteins by calnexin. Science 263: 387-390.
31. Witheiler J, Wilson DB, (1972) The purification and characterization of a novel peptidase from sheep red cells. J Biol Chem 247: 2217-2221.
32. Huberts DH, van der Klei IJ, (2010) Moonlighting proteins: an intriguing mode of multitasking. Biochim Biophys Acta 1803: 520-525.
33. Jeffery CJ, (2009) Moonlighting proteins-an update. Mol Biosyst 5: 345-350.
34. Yang W, Xia Y, Ji H, Zheng Y, Liang J, et al. (2011) Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature.
35. Cox BJ, Vollmer M, Tamplin O, Lu M, Biechele S, et al. (2010) Phenotypic annotation of the mouse X chromosome. Genome Res 20: 1154-1164.
36. Grzeschik KH, Bornholdt D, Oeffner F, Konig A, del Carmen Boente M, et al. (2007) Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia. Nat Genet 39: 833-835.
37. Wang X, Reid Sutton V, Omar Peraza-Llanes J, Yu Z, Rosetta R, et al. (2007) Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia. Nat Genet 39: 836-838.
38. Froyen G, Govaerts K, Van Esch H, Verbeeck J, Tuomi ML, et al. (2009) Novel PORCN mutations in focal dermal hypoplasia. Clin Genet 76: 535-543.